BioSpace News Archive

Drug Development

Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Patients with Atopic Dermatitis

Cara Therapeutics, Inc. announced the initiation of a Phase 2 trial of Oral KORSUVA for the treatment of pruritus in patients with atopic dermatitis.

July 9, 2019
·
4 min read
Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and Pneumonia

Summit Therapeutics plc announces that it has demonstrated the potential of its DDS-04 series of new class antibiotics as an Enterobacteriaceae-targeted treatment through in vivo proof of concept data in sepsis and pneumonia animal models.

July 9, 2019
·
6 min read
Policy

Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADE® (Oxymetazoline Hydrochloride) Cream, 1%

Issuance of U.S. Patent No. 10,335,391 Further Strengthens Aclaris’ RHOFADE Patent Portfolio

July 9, 2019
·
5 min read
BioMidwest

WindMIL Therapeutics and University of Michigan Announce Collaboration to Collect Bone Marrow from Patients with Head and Neck Cancer to Develop Marrow Infiltrating Lymphocytes (MILs™)

WindMIL Therapeutics and the University of Michigan Rogel Cancer Center today announced that the first patients have been identified in an investigator-sponsored study for the collection of bone marrow from patients with head and neck squamous cell carcinoma.

July 9, 2019
·
3 min read
Deals

Immutep Raises A$10 Million Via Private Placement and Underwritten Entitlement Offer

Immutep Limited, an Australian biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, has announced an equity financing to raise gross proceeds of approximately A$10 million.

July 9, 2019
·
3 min read
Policy

CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data

CorMedix Inc. announced that it has received feedback from the U.S. FDA regarding the submitted statistical analyses of data and additional information requested by the FDA for the primary and secondary efficacy endpoints of the Company’s LOCK-IT-100 clinical study.

July 9, 2019
·
4 min read
Business

Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster® EDC

Symbio LLC, a client-focused, full-service clinical research organization, has signed a five-year contract with OmniComm Systems, Inc., a leading global provider of clinical data management technology.

July 9, 2019
·
2 min read
Policy

Reston Hospital Center Receives Get With The Guidelines Target: Stroke Honor Roll Elite Gold Plus Quality Achievement Award

Reston Hospital Center has received the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Gold Plus Quality Achievement Award.

July 9, 2019
·
3 min read
Deals

Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split

Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, announced preliminary financial results for the quarter ended June 30, 2019.

July 9, 2019
·
5 min read
IBA signs contract to install proton therapy center in Kansas, USA

Construction to host IBA’s Proteus®ONE system expected to start later this year

July 9, 2019
·
4 min read